ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,804.64
-0.41%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Armata Pharmaceuticals Inc (ARMP)

  7. Armata Pharmaceuticals Inc (ARMP) Noticias

ARMP

Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:ARMP
FechaHoraFuenteTítuloSímboloCompañía
07/05/202415:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
07/05/202415:15Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
04/03/202416:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
23/01/202415:17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
26/12/202320:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
22/09/202318:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202315:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202315:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202315:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
24/07/202315:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
27/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
11/05/202315:07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ARMPArmata Pharmaceuticals Inc
16/03/202315:07Edgar (US Regulatory)Annual Report (10-k)AMEX:ARMPArmata Pharmaceuticals Inc
13/02/202314:42Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:ARMPArmata Pharmaceuticals Inc
07/02/202315:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ARMPArmata Pharmaceuticals Inc
10/11/202205:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
15/08/202206:45TipRanksLadenburg Thalmann & Co. Remains a Buy on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
12/08/202205:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
01/08/202208:28TipRanksArmata Pharmaceuticals (ARMP) Receives a Buy from H.C. WainwrightAMEX:ARMPArmata Pharmaceuticals Inc
01/06/202205:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:ARMPArmata Pharmaceuticals Inc
24/05/202205:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:ARMPArmata Pharmaceuticals Inc
16/05/202205:45TipRanksArmata Pharmaceuticals (ARMP) Gets a Buy Rating from Ladenburg Thalmann & Co.AMEX:ARMPArmata Pharmaceuticals Inc
15/04/202214:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ARMPArmata Pharmaceuticals Inc
01/04/202215:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:ARMPArmata Pharmaceuticals Inc
18/03/202205:35TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksAMEX:ARMPArmata Pharmaceuticals Inc
24/02/202215:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:ARMPArmata Pharmaceuticals Inc
07/01/202206:55TipRanksLadenburg Thalmann & Co. Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
05/01/202209:35TipRanksH.C. Wainwright Maintains Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
22/04/202105:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:ARMPArmata Pharmaceuticals Inc
21/04/202116:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ARMPArmata Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:ARMP

Su Consulta Reciente

BIT
S25013
SG ISSUER
COIN
DUBUSD
LSE
0N7H
BOV
VALEF572
VALEF572 Ex:54,49
LSE
LVLG
Iqs Ge Lvlc Acc
NASDAQI
IPKW
PowerShares Internationa...
COIN
COGBTC
BIT
F18863
Vontobel Financial Produ...
BITMOT
899753
Obligaciones Green Bond ...
USOTC
CDAB
Coeur D Alene Bancorp (PK)
CSE
VYGR
Voyager Digital
NASDAQ
WWTAMX
Wilmington Trust TRowe P...
LSE
67WQ
Hsbc Bk. 26
USOTC
CATKU
Catskill Litigation (CE)
USOTC
SAML
Samsara Luggage (PK)
ASX
FRS
Forrestania Resources
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados